The Experts below are selected from a list of 168 Experts worldwide ranked by ideXlab platform
Rutger Dahmen - One of the best experts on this subject based on the ideXlab platform.
-
Therapeutic Footwear for the Neuropathic Foot
2020Co-Authors: Rutger Dahmen, Rob Haspels, Bart Koomen, Agnes F. HoeksmaAbstract:Neuropathy may bring about changes in form and function of the foot, which may lead to ulceration and progressive deformity. These manifestations often require specially adapted footwear. A comprehensive concept of the medical, functional, and technical requirements for this type of footwear is still lacking to date. In this article, we present an algorithm that should facilitate prescription and manufacture of adequate Shoes. This algorithm attempts to establish a link between the requirements from a medical and functional point of view and the technical possibilities of Orthopedic Shoe technology. Diabetes Care 24:705‐709, 2001
-
Delphi process yielded consensus on terminology and research agenda for therapeutic footwear for neuropathic foot
Journal of Clinical Epidemiology, 2020Co-Authors: Rutger Dahmen, Gelske J. Van Der Wilden, Gustaaf J. Lankhorst, Maarten BoersAbstract:Objective: To investigate areas of consensus and disagreement among Dutch physiatrists concerning prescription of therapeutic footwear for the neuropathic foot and to develop a research agenda. Study Design and Setting: Forty participants were physiatrists and experts in the field of Orthopedic Shoe techniques. Four postal Delphi rounds were followed by a final plenary session. Results: Forty of the 44 invited experts participated in all postal Delphi rounds, with an overall response of 100%. They achieved consensus on the following. 1. (Dutch) Terminology for two sets of domains and dimensions for the various features of the neuropathic foot and for the Shoe characteristics. 2. Application of specific Shoe components: insole, shaft, outsole, tongue, and heel. In most features of the neuropathic foot, shaft and outsole domains were linked in the flexibility dimension. 3. Shoe prescriptions for various features of the neuropathic foot in at least four technical domains. Experts disagreed on application of rocker bar and shaft height. In a final conference, 31 experts agreed on a prioritized research agenda. Conclusion: An intensive Delphi process yielded consensus on terminology, and determined areas of consensus and disagreement for future research for the various features of the neuropathic foot and the Shoe characteristics. © 2008 Elsevier Inc. All rights reserved
-
Delphi process yielded consensus on terminology and research agenda for therapeutic footwear for neuropathic foot.
Journal of Clinical Epidemiology, 2008Co-Authors: Rutger Dahmen, Gelske J. Van Der Wilden, Gustaaf J. Lankhorst, Maarten BoersAbstract:Abstract Objective To investigate areas of consensus and disagreement among Dutch physiatrists concerning prescription of therapeutic footwear for the neuropathic foot and to develop a research agenda. Study Design and Setting Forty participants were physiatrists and experts in the field of Orthopedic Shoe techniques. Four postal Delphi rounds were followed by a final plenary session. Results Forty of the 44 invited experts participated in all postal Delphi rounds, with an overall response of 100%. They achieved consensus on the following. 1. (Dutch) Terminology for two sets of domains and dimensions for the various features of the neuropathic foot and for the Shoe characteristics. 2. Application of specific Shoe components: insole, shaft, outsole, tongue, and heel. In most features of the neuropathic foot, shaft and outsole domains were linked in the flexibility dimension. 3. Shoe prescriptions for various features of the neuropathic foot in at least four technical domains. Experts disagreed on application of rocker bar and shaft height. In a final conference, 31 experts agreed on a prioritized research agenda. Conclusion An intensive Delphi process yielded consensus on terminology, and determined areas of consensus and disagreement for future research for the various features of the neuropathic foot and the Shoe characteristics.
-
Therapeutic footwear for the neuropathic foot: An algorithm
Diabetes Care, 2001Co-Authors: Rutger Dahmen, Rob Haspels, Bart Koomen, Agnes F. HoeksmaAbstract:Neuropathy may bring about changes in form and function of the foot, which may lead to ulceration and progressive deformity. These manifestations often require specially adapted footwear. A comprehensive concept of the medical, functional, and technical requirements for this type of footwear is still lacking to date. In this article, We present an algorithm that should facilitate prescription and manufacture of adequate Shoes. This algorithm attempts to establish a link between the requirements from a medical and functional point of view and the technical possibilities of Orthopedic Shoe technology.
Cornelia F. Allaart - One of the best experts on this subject based on the ideXlab platform.
-
Erosions in the foot at baseline are predictive of orthopaedic Shoe use after 10 years of treat to target therapy in patients with recent onset rheumatoid arthritis
Clinical Rheumatology, 2016Co-Authors: Sytske Anne Bergstra, Pit J.s.m. Kerstens, Iris M. Markusse, Gülşah Akdemir, H. Karel Ronday, K. Huub Han, Robert B. M. Landewé, Rosaline Van Den Berg, Willem F Lems, Cornelia F. AllaartAbstract:The objective of this study is to investigate if foot joint damage due to rheumatoid arthritis (RA) can predict whether patients will start wearing orthopaedic Shoes (OS) within 10 years after treatment start. Data from recent onset RA patients with 10 years follow-up from the BeSt (Dutch acronym for treatment strategies) study were used. Treatment was tightly controlled, targeted at disease activity score (DAS) ≤2.4, according to 1 of 4 pre-specified treatment strategies. After 10 years of follow-up, orthopaedic Shoe use was recorded in 285/508 patients (responders to questionnaires at 10 years). Between-group differences for orthopaedic Shoe users and non-users were calculated at baseline, after 10 years, and change scores over the 10-year period were calculated. Predictors for orthopaedic Shoe use were identified by univariable and multivariable logistic regression analyses. Orthopaedic Shoe use was reported by 57/285 patients after 10 years. Orthopaedic Shoe users had more joint damage, joint swelling and pain in the feet already at baseline and after 10 years. At both time points, DAS of orthopaedic Shoe users and non-users was similar. Multivariable logistic regression showed that dichotomized foot erosions score (cut-off ≥1 erosion) (OR 2.42), anti-citrullinated protein antibodies (ACPA) (OR 4.64) and DAS (OR 1.77) were independent predictors of orthopaedic Shoe use. Despite intensive targeted treatment, 57/285 recent onset RA patients started using orthopaedic Shoes over 10 year of follow-up. Presence of foot erosions at treatment start predicts orthopaedic Shoe use after 10 years. The risk of Orthopedic Shoe use increased for ACPA-positive patients and for those with higher baseline disease activity.
-
Erosions in the foot at baseline are predictive of orthopaedic Shoe use after 10 years of treat to target therapy in patients with recent onset rheumatoid arthritis
Clinical Rheumatology, 2015Co-Authors: Sytske Anne Bergstra, Pit J.s.m. Kerstens, Iris M. Markusse, Gülşah Akdemir, H. Karel Ronday, Robert B. M. Landewé, Willem F Lems, R. Van Den Berg, Cornelia F. AllaartAbstract:The objective of this study is to investigate if foot joint damage due to rheumatoid arthritis (RA) can predict whether patients will start wearing orthopaedic Shoes (OS) within 10 years after treatment start. Data from recent onset RA patients with 10 years follow-up from the BeSt (Dutch acronym for treatment strategies) study were used. Treatment was tightly controlled, targeted at disease activity score (DAS) ≤2.4, according to 1 of 4 pre-specified treatment strategies. After 10 years of follow-up, orthopaedic Shoe use was recorded in 285/508 patients (responders to questionnaires at 10 years). Between-group differences for orthopaedic Shoe users and non-users were calculated at baseline, after 10 years, and change scores over the 10-year period were calculated. Predictors for orthopaedic Shoe use were identified by univariable and multivariable logistic regression analyses. Orthopaedic Shoe use was reported by 57/285 patients after 10 years. Orthopaedic Shoe users had more joint damage, joint swelling and pain in the feet already at baseline and after 10 years. At both time points, DAS of orthopaedic Shoe users and non-users was similar. Multivariable logistic regression showed that dichotomized foot erosions score (cut-off ≥1 erosion) (OR 2.42), anti-citrullinated protein antibodies (ACPA) (OR 4.64) and DAS (OR 1.77) were independent predictors of orthopaedic Shoe use. Despite intensive targeted treatment, 57/285 recent onset RA patients started using orthopaedic Shoes over 10 year of follow-up. Presence of foot erosions at treatment start predicts orthopaedic Shoe use after 10 years. The risk of Orthopedic Shoe use increased for ACPA-positive patients and for those with higher baseline disease activity.
-
FRI0055 Erosions in the Foot at Baseline are Predictive of Orthopedic Shoes Use After 10 Years of Treat to Target Therapy – Results from the Best Study
Annals of the Rheumatic Diseases, 2015Co-Authors: Sytske Anne Bergstra, Pit J.s.m. Kerstens, Robert B. M. Landewé, Willem F Lems, R. Van Den Berg, C. Bijkerk, A.h. Gerards, Rj Goekoop, T W J Huizinga, Cornelia F. AllaartAbstract:Background Foot problems developing during the disease course of rheumatoid arthritis (RA) patients can cause decreased mobility and quality of life. Orthopedic Shoes may help to reduce pain and increase activity participation in RA patients. Objectives To investigate if foot damage due to RA can predict if patients will wear Orthopedic Shoes within 10 years after treatment start. Methods In the four treatment arms of the BeSt study, 508 patients with recent onset RA were treated to target (disease activity score (DAS) ≤2.4). After 10 years, patients were asked if they used Orthopedic Shoes. Univariable binary logistic regression was performed with Orthopedic Shoe use as outcome variable and baseline total Sharp/van der Heijde score (SHS), foot erosions and foot joint space narrowing (JSN) as continuous and binary variables (score >0.5 yes/no) as potential predictors. Next, rheumatoid factor (RF), smoking (yes/no), anti-citrullinated protein antibodies (ACPA), DAS and age were simultaneously added as predictors in a multivariable model, in combination with the statistically significant predictors (p Results Of 285/508 patients (56.1%) information was available regarding Orthopedic Shoe use. Responders were younger than non-responders [age mean (SD) 51.3 (12.0) vs 58.4 (14.8) years, p Conclusions Despite 10 years of DAS ≤2.4 targeted treatment, 20% of recent onset RA patients with available data after 10 year used Orthopedic Shoes. Presence of foot erosions at treatment start predicts the use of Orthopedic Shoes after 10 years. The risk of Orthopedic Shoe use increases for ACPA+ patients and to a lesser extent for patients with higher baseline DAS. Disclosure of Interest S. Bergstra: None declared, R. van den Berg: None declared, C. Bijkerk: None declared, A. Gerards: None declared, R. Goekoop: None declared, P. Kerstens: None declared, W. Lems: None declared, T. Huizinga: None declared, R. Landewe: None declared, C. Allaart Grant/research support from: The study was designed by the investigators and supported by a government grant from the Dutch Insurance Companies, with additional funding from Schering-Plough B.V. and Janssen B.V. Data collection, trial management, data analysis and preparation of the manuscript were performed by the authors.
Agnes F. Hoeksma - One of the best experts on this subject based on the ideXlab platform.
-
Therapeutic Footwear for the Neuropathic Foot
2020Co-Authors: Rutger Dahmen, Rob Haspels, Bart Koomen, Agnes F. HoeksmaAbstract:Neuropathy may bring about changes in form and function of the foot, which may lead to ulceration and progressive deformity. These manifestations often require specially adapted footwear. A comprehensive concept of the medical, functional, and technical requirements for this type of footwear is still lacking to date. In this article, we present an algorithm that should facilitate prescription and manufacture of adequate Shoes. This algorithm attempts to establish a link between the requirements from a medical and functional point of view and the technical possibilities of Orthopedic Shoe technology. Diabetes Care 24:705‐709, 2001
-
Therapeutic footwear for the neuropathic foot: An algorithm
Diabetes Care, 2001Co-Authors: Rutger Dahmen, Rob Haspels, Bart Koomen, Agnes F. HoeksmaAbstract:Neuropathy may bring about changes in form and function of the foot, which may lead to ulceration and progressive deformity. These manifestations often require specially adapted footwear. A comprehensive concept of the medical, functional, and technical requirements for this type of footwear is still lacking to date. In this article, We present an algorithm that should facilitate prescription and manufacture of adequate Shoes. This algorithm attempts to establish a link between the requirements from a medical and functional point of view and the technical possibilities of Orthopedic Shoe technology.
Maarten Boers - One of the best experts on this subject based on the ideXlab platform.
-
Delphi process yielded consensus on terminology and research agenda for therapeutic footwear for neuropathic foot
Journal of Clinical Epidemiology, 2020Co-Authors: Rutger Dahmen, Gelske J. Van Der Wilden, Gustaaf J. Lankhorst, Maarten BoersAbstract:Objective: To investigate areas of consensus and disagreement among Dutch physiatrists concerning prescription of therapeutic footwear for the neuropathic foot and to develop a research agenda. Study Design and Setting: Forty participants were physiatrists and experts in the field of Orthopedic Shoe techniques. Four postal Delphi rounds were followed by a final plenary session. Results: Forty of the 44 invited experts participated in all postal Delphi rounds, with an overall response of 100%. They achieved consensus on the following. 1. (Dutch) Terminology for two sets of domains and dimensions for the various features of the neuropathic foot and for the Shoe characteristics. 2. Application of specific Shoe components: insole, shaft, outsole, tongue, and heel. In most features of the neuropathic foot, shaft and outsole domains were linked in the flexibility dimension. 3. Shoe prescriptions for various features of the neuropathic foot in at least four technical domains. Experts disagreed on application of rocker bar and shaft height. In a final conference, 31 experts agreed on a prioritized research agenda. Conclusion: An intensive Delphi process yielded consensus on terminology, and determined areas of consensus and disagreement for future research for the various features of the neuropathic foot and the Shoe characteristics. © 2008 Elsevier Inc. All rights reserved
-
Delphi process yielded consensus on terminology and research agenda for therapeutic footwear for neuropathic foot.
Journal of Clinical Epidemiology, 2008Co-Authors: Rutger Dahmen, Gelske J. Van Der Wilden, Gustaaf J. Lankhorst, Maarten BoersAbstract:Abstract Objective To investigate areas of consensus and disagreement among Dutch physiatrists concerning prescription of therapeutic footwear for the neuropathic foot and to develop a research agenda. Study Design and Setting Forty participants were physiatrists and experts in the field of Orthopedic Shoe techniques. Four postal Delphi rounds were followed by a final plenary session. Results Forty of the 44 invited experts participated in all postal Delphi rounds, with an overall response of 100%. They achieved consensus on the following. 1. (Dutch) Terminology for two sets of domains and dimensions for the various features of the neuropathic foot and for the Shoe characteristics. 2. Application of specific Shoe components: insole, shaft, outsole, tongue, and heel. In most features of the neuropathic foot, shaft and outsole domains were linked in the flexibility dimension. 3. Shoe prescriptions for various features of the neuropathic foot in at least four technical domains. Experts disagreed on application of rocker bar and shaft height. In a final conference, 31 experts agreed on a prioritized research agenda. Conclusion An intensive Delphi process yielded consensus on terminology, and determined areas of consensus and disagreement for future research for the various features of the neuropathic foot and the Shoe characteristics.
Sytske Anne Bergstra - One of the best experts on this subject based on the ideXlab platform.
-
Erosions in the foot at baseline are predictive of orthopaedic Shoe use after 10 years of treat to target therapy in patients with recent onset rheumatoid arthritis
Clinical Rheumatology, 2016Co-Authors: Sytske Anne Bergstra, Pit J.s.m. Kerstens, Iris M. Markusse, Gülşah Akdemir, H. Karel Ronday, K. Huub Han, Robert B. M. Landewé, Rosaline Van Den Berg, Willem F Lems, Cornelia F. AllaartAbstract:The objective of this study is to investigate if foot joint damage due to rheumatoid arthritis (RA) can predict whether patients will start wearing orthopaedic Shoes (OS) within 10 years after treatment start. Data from recent onset RA patients with 10 years follow-up from the BeSt (Dutch acronym for treatment strategies) study were used. Treatment was tightly controlled, targeted at disease activity score (DAS) ≤2.4, according to 1 of 4 pre-specified treatment strategies. After 10 years of follow-up, orthopaedic Shoe use was recorded in 285/508 patients (responders to questionnaires at 10 years). Between-group differences for orthopaedic Shoe users and non-users were calculated at baseline, after 10 years, and change scores over the 10-year period were calculated. Predictors for orthopaedic Shoe use were identified by univariable and multivariable logistic regression analyses. Orthopaedic Shoe use was reported by 57/285 patients after 10 years. Orthopaedic Shoe users had more joint damage, joint swelling and pain in the feet already at baseline and after 10 years. At both time points, DAS of orthopaedic Shoe users and non-users was similar. Multivariable logistic regression showed that dichotomized foot erosions score (cut-off ≥1 erosion) (OR 2.42), anti-citrullinated protein antibodies (ACPA) (OR 4.64) and DAS (OR 1.77) were independent predictors of orthopaedic Shoe use. Despite intensive targeted treatment, 57/285 recent onset RA patients started using orthopaedic Shoes over 10 year of follow-up. Presence of foot erosions at treatment start predicts orthopaedic Shoe use after 10 years. The risk of Orthopedic Shoe use increased for ACPA-positive patients and for those with higher baseline disease activity.
-
Erosions in the foot at baseline are predictive of orthopaedic Shoe use after 10 years of treat to target therapy in patients with recent onset rheumatoid arthritis
Clinical Rheumatology, 2015Co-Authors: Sytske Anne Bergstra, Pit J.s.m. Kerstens, Iris M. Markusse, Gülşah Akdemir, H. Karel Ronday, Robert B. M. Landewé, Willem F Lems, R. Van Den Berg, Cornelia F. AllaartAbstract:The objective of this study is to investigate if foot joint damage due to rheumatoid arthritis (RA) can predict whether patients will start wearing orthopaedic Shoes (OS) within 10 years after treatment start. Data from recent onset RA patients with 10 years follow-up from the BeSt (Dutch acronym for treatment strategies) study were used. Treatment was tightly controlled, targeted at disease activity score (DAS) ≤2.4, according to 1 of 4 pre-specified treatment strategies. After 10 years of follow-up, orthopaedic Shoe use was recorded in 285/508 patients (responders to questionnaires at 10 years). Between-group differences for orthopaedic Shoe users and non-users were calculated at baseline, after 10 years, and change scores over the 10-year period were calculated. Predictors for orthopaedic Shoe use were identified by univariable and multivariable logistic regression analyses. Orthopaedic Shoe use was reported by 57/285 patients after 10 years. Orthopaedic Shoe users had more joint damage, joint swelling and pain in the feet already at baseline and after 10 years. At both time points, DAS of orthopaedic Shoe users and non-users was similar. Multivariable logistic regression showed that dichotomized foot erosions score (cut-off ≥1 erosion) (OR 2.42), anti-citrullinated protein antibodies (ACPA) (OR 4.64) and DAS (OR 1.77) were independent predictors of orthopaedic Shoe use. Despite intensive targeted treatment, 57/285 recent onset RA patients started using orthopaedic Shoes over 10 year of follow-up. Presence of foot erosions at treatment start predicts orthopaedic Shoe use after 10 years. The risk of Orthopedic Shoe use increased for ACPA-positive patients and for those with higher baseline disease activity.
-
FRI0055 Erosions in the Foot at Baseline are Predictive of Orthopedic Shoes Use After 10 Years of Treat to Target Therapy – Results from the Best Study
Annals of the Rheumatic Diseases, 2015Co-Authors: Sytske Anne Bergstra, Pit J.s.m. Kerstens, Robert B. M. Landewé, Willem F Lems, R. Van Den Berg, C. Bijkerk, A.h. Gerards, Rj Goekoop, T W J Huizinga, Cornelia F. AllaartAbstract:Background Foot problems developing during the disease course of rheumatoid arthritis (RA) patients can cause decreased mobility and quality of life. Orthopedic Shoes may help to reduce pain and increase activity participation in RA patients. Objectives To investigate if foot damage due to RA can predict if patients will wear Orthopedic Shoes within 10 years after treatment start. Methods In the four treatment arms of the BeSt study, 508 patients with recent onset RA were treated to target (disease activity score (DAS) ≤2.4). After 10 years, patients were asked if they used Orthopedic Shoes. Univariable binary logistic regression was performed with Orthopedic Shoe use as outcome variable and baseline total Sharp/van der Heijde score (SHS), foot erosions and foot joint space narrowing (JSN) as continuous and binary variables (score >0.5 yes/no) as potential predictors. Next, rheumatoid factor (RF), smoking (yes/no), anti-citrullinated protein antibodies (ACPA), DAS and age were simultaneously added as predictors in a multivariable model, in combination with the statistically significant predictors (p Results Of 285/508 patients (56.1%) information was available regarding Orthopedic Shoe use. Responders were younger than non-responders [age mean (SD) 51.3 (12.0) vs 58.4 (14.8) years, p Conclusions Despite 10 years of DAS ≤2.4 targeted treatment, 20% of recent onset RA patients with available data after 10 year used Orthopedic Shoes. Presence of foot erosions at treatment start predicts the use of Orthopedic Shoes after 10 years. The risk of Orthopedic Shoe use increases for ACPA+ patients and to a lesser extent for patients with higher baseline DAS. Disclosure of Interest S. Bergstra: None declared, R. van den Berg: None declared, C. Bijkerk: None declared, A. Gerards: None declared, R. Goekoop: None declared, P. Kerstens: None declared, W. Lems: None declared, T. Huizinga: None declared, R. Landewe: None declared, C. Allaart Grant/research support from: The study was designed by the investigators and supported by a government grant from the Dutch Insurance Companies, with additional funding from Schering-Plough B.V. and Janssen B.V. Data collection, trial management, data analysis and preparation of the manuscript were performed by the authors.
